Tema Cardiovascular and Metabolics ETF (HRTS) Holdings $28.67 -0.56 (-1.92%) As of 03:58 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestTrends Top 43 HRTS HoldingsRankCompanyCurrent PriceWeightShares Held1LLYEli Lilly and Company$733.79-8.0%7.42%6,4352VRTXVertex Pharmaceuticals$412.18-0.3%5.25%8,7233ALNYAlnylam Pharmaceuticals$250.87-2.9%5.04%14,3414BBIOBridgeBio Pharma$35.90+6.4%4.43%108,0955Chugai Pharmaceutical Co., Ltd.N/A4.01%60,2916ASNDAscendis Pharma A/S$135.82+1.3%3.92%19,040 Get the Latest News and Ratings for HRTS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Cardiovascular and Metabolics ETF and its competitors with MarketBeat's FREE daily newsletter. 7CRNXCrinetics Pharmaceuticals$36.85-5.5%3.83%50,1458AstraZeneca PLCN/A3.76%19,1809Novo Nordisk A/SN/A3.37%25,98710CYTKCytokinetics$45.60-2.4%3.33%47,38311AMGNAmgen$266.16-1.5%3.32%8,51412Roche Holding AGN/A3.30%63,31213DXCMDexCom$77.76-2.6%3.00%25,78014MREOMereo BioPharma Group$3.13-6.3%2.83%540,73115BSXBoston Scientific$95.06+0.5%2.74%20,49416MIRMMirum Pharmaceuticals$43.95-0.1%2.59%41,96817IONSIonis Pharmaceuticals$34.12-2.3%2.54%48,52618EWEdwards Lifesciences$70.80-0.4%2.39%21,63519MASIMasimo$165.73+0.1%2.37%9,58020PODDInsulet$264.44-1.3%2.10%5,38521MDTMedtronic$84.77+3.6%2.06%17,27022REGNRegeneron Pharmaceuticals$699.28-2.5%2.03%1,90423GPCRStructure Therapeutics$24.74-1.7%1.80%44,34324ARWRArrowhead Pharmaceuticals$18.20-3.8%1.73%61,50325RCKTRocket Pharmaceuticals$10.38-3.3%1.71%90,98526MDGLMadrigal Pharmaceuticals$286.83-5.6%1.67%3,62027MLYSMineralys Therapeutics$9.07-3.1%1.65%89,52928WSTWest Pharmaceutical Services$329.76-2.9%1.56%3,18029NTLAIntellia Therapeutics$9.79-2.6%1.43%81,99730AKROAkero Therapeutics$21.96-3.0%1.34%32,15031Novartis AGN/A1.32%9,05832Zealand Pharma A/SN/A1.31%8,81433TMOThermo Fisher Scientific$557.20+0.3%1.26%1,62334VKTXViking Therapeutics$34.60-11.0%1.22%20,21535NARIInari Medical$79.30-0.1%1.13%14,79036INSMInsmed$68.45-0.7%1.10%10,62637Gubra A/SN/A0.92%7,08038SLNOSoleno Therapeutics$42.98-0.2%0.89%13,17839KROSKeros Therapeutics$12.59-1.8%0.84%35,66340VERVVerve Therapeutics$5.32-3.3%0.75%89,239 41TERNTerns Pharmaceuticals$4.69-2.3%0.66%79,69642Treasury Obligations FundN/A0.15%98,00543DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A-0.03%441,930,928 Geographic ExposureUnited States83.1%Denmark5.3%United Kingdom3.7%Japan3.1%Ireland2.5%Switzerland1.3%Currency ExposureUSD85.6%DKK6.3%GBP3.7%JPY3.1%CHF1.3%Sector ExposureHealth Care84.3%Industry ExposureBiotechnology52.6%Health Care Equipment & Supplies22.6%Health Care Providers & Services6.3%Health Care Technology1.5%Pharmaceuticals1.3%SubIndustry ExposureBiotechnology47.8%Health Care Equipment12.9%Life Sciences Tools & Services8.1%Managed Health Care6.3%Pharmaceuticals4.7%Health Care Supplies1.6%Health Care Distributors1.5%Coupon Exposure4-60.4%Maturity Exposure15-200.4% Related Companies and Tools Related Companies Tradr 2X Long Innovation ETF Portfolio Companies Global X E-Commerce ETF Portfolio Companies Siren Nasdaq NexGen Economy ETF Portfolio Companies Global X Genomics & Biotechnology ETF Portfolio Companies CrossingBridge Pre-Merger SPAC ETF Portfolio Companies Invesco ESG NASDAQ 100 ETF Portfolio Companies Global X Data Center & Digital Infrastructure ETF Portfolio Companies Fidelity Disruptive Communications ETF Portfolio Companies Global X Aging Population ETF Portfolio Companies Roundhill Daily 2X Long Magnificent Seven ETF Portfolio Companies This page (NASDAQ:HRTS) was last updated on 1/14/2025 by MarketBeat.com Staff From Our PartnersStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in JanuaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Cardiovascular and Metabolics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Cardiovascular and Metabolics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
